Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Robitussin To Go spoons

This article was originally published in The Tan Sheet

Executive Summary

Wyeth Consumer Healthcare promotes pre-filled spoons of Robitussin Cough & Chest Congestion DM (dextromethorphan/guaifenesin) and Cough & Cold CF (dextromethorphan/guaifenesin/phenylephrine) for adult convenience. The two Robitussin To Go products are available nationwide at a suggested retail price of $8.69 for 10-count packs, a spokeswoman said in an e-mail. The products are indicated for consumers 12 years and older. Wyeth markets the products to consumers who "want a portable form for added convenience when they're on the go or away from home," the spokeswoman added. Robitussin To Go uses the RiteDose delivery system from The Ritedose Corp., which provides a similar device for McNeil Consumer Healthcare's pediatric allergy products Zyrtec Perfect Measure (cetirizine) and Benadryl Perfect Measure (diphenhydramine) (1"The Tan Sheet" Oct. 19, 2009)

You may also be interested in...



Dosing Device Paradigm Shifts For Liquid OTCs In Wake Of Safety Concerns

OTC drug manufacturers must consider a dosing device as a primary element of liquid product packaging to improve consumer safety through proper dosing, industry stakeholders say

Prenatal Vitamin D Benefit In Preventing Childhood Asthma Fades By Age 6

University of Rochester researchers say a benefit of daily prenatal vitamin D in preventing asthma in children up to 3 found in their 2016 study doesn't extend until age 6. They encourage more research, including analyzing whether supplementation should continue in young children.

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

At the end of the Brexit transition period, the UK will be charting its own course through the often choppy seas of medicines regulation. While it plans to retain the existing EU rules that have been transposed into domestic legislation, it also wants the freedom to tailor its regulations in areas like clinical trials, advanced therapies and product labeling.

Topics

UsernamePublicRestriction

Register

PS103488

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel